// App-Quantinova.ai

: Twenty-four infusion of human recombinant activated protein C (Xigris) as a disease-modifier early in severe acute pancreatiti the final results of the Xigap 1 study

Researchers

Presenter

  • A.K. Siriwardena

Principal Investigators

  • C.C. Miranda

  • J.M. Mason

  • B.I. Babu

Medical Centers

  • School of Medicine and Health, University of Durham, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Pancreatitis

  • Gallbladder disease

Biomarkers

  • N/A

Drug/Treatment

  • Protein C

  • Xigris

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved